Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies.
Oster P, Vaillant L, Riva E, McMillan B, Begka C, Truntzer C, Richard C, Leblond MM, Messaoudene M, Machremi E, Limagne E, Ghiringhelli F, Routy B, Verdeil G, Velin D.
Oster P, et al. Among authors: leblond mm.
Gut. 2022 Mar;71(3):457-466. doi: 10.1136/gutjnl-2020-323392. Epub 2021 Jul 12.
Gut. 2022.
PMID: 34253574
Free PMC article.